Caliber Imaging & Diagnostics Appoints Robert P. Fischmann as VP of Operations, a Newly Created Position

BOSTON and ROCHESTER, N.Y., Nov. 25, 2013 (GLOBE NEWSWIRE) -- Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has appointed Robert P. Fischmann to the role of Vice President of Operations, a newly created position.

L. Michael Hone, Chief Executive Officer of Caliber I.D., said, "As we prepare for the anticipated growth of our company, we have reached the point where we will benefit from the expertise of an experienced, seasoned operations professional. I am honored that Robert Fischmann, with his substantial global and domestic experience, has accepted this role. Robert will report directly to me, and I am confident he will excel in overseeing the direction, strategy, planning and execution of our manufacturing operations activities."

Mr. Fischmann, age 54, is a seasoned executive with more than three decades of experience in management and operations roles within technically oriented product companies. Between 1981 and 2011, he held positions of increasing responsibility at Eastman Kodak Company. Most recently, he served as Director-Worldwide Operations and Customer Service & Vice President, Prepress Solutions. In this role he was responsible for all manufacturing operations, customer service engineering, and field technical assistance within Eastman Kodak's $1.6B Prepress Solutions business. He holds a BS degree in mechanical engineering from Union College, an MS degree in manufacturing and engineering management from Clarkson University and an MBA from Rochester Institute of Technology.

Mr. Fischmann's responsibilities at Caliber I.D. will include managing all of the Company's production control, production process development, quality systems, purchasing, shipping/ receiving, customer support and FDA compliance activities. He will also liaise with CEO Michael Hone on manufacturing plans and future innovations, and consult on product design for manufacturability.

Mr. Fischmann stated, "Caliber I.D.'s goal of advancing its confocal microscopy technology will require a streamlined manufacturing operations process that incorporates a firm knowledge of the life science market. With effective operations strategies in place, it is my belief that the Company will cement its reputation as a leader in its field. I look forward to serving as Vice President of Operations and working with the management team as the Company moves ahead."

About Caliber Imaging & Diagnostics

Caliber Imaging & Diagnostics' platform of products offer increased productivity from the research laboratory to the doctor's office or the surgeon's operating room. Caliber I.D.'s platform of products provide precise accuracy, consistent reliability, and online backup that all combine to lead to better patient care. For more information about Caliber I.D. and its products, please visit

VivaScope(R) is a registered trademark of Caliber Imaging & Diagnostics.

Safe Harbor

This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the Forms 10-Q and 10-K filed by us with the Securities and Exchange Commission.

CONTACT: Richard Pulsifer Chief Financial Officer (617) 348-9821 Investor Relations: Dian Griesel Int'l. Cheryl Schneider (212) 825-3210 Public Relations: Dian Griesel Int'l. Susan Forman or Laura Radocaj (212) 825-3210 lradocaj@dgicomm.comSource:Caliber Imaging & Diagnostics, Inc.